European Archives - Page 352 of 1112 - European Medical Journal

Haematology under the microscope

This infographic explores the vastness of the haematology market, including key industry players, drugs to watch, the global burden of haematological diseases and more.

Methotrexate a Low-Cost, Effective Treatment for Inflammatory Joint Conditions

Researchers from Monash University, Clayton, Victoria, Australia, found that 20 mg weekly methotrexate delivered orally over 6 months reduced pain and stiffness in patients with symptomatic hand osteoarthritis.

Why HCPs are losing trust in pharma marketing

Discover why healthcare professionals are losing trust in pharma marketing. Listen the episode as the GOLD team delves into the industry’s challenges.

Learn to SHARE the decision for dialysis modality selection

In this interactive case study, healthcare professionals have the opportunity to learn more about the SHARE approach for shared…

Greater Osteoarthritis Progression Observed in Patients Undergoing Meniscal Surgery

Greater osteophyte progression has been observed in patients who underwent arthroscopic meniscal surgery, compared with those receiving physical therapy. Read more.

Spotlight: October 2023

Discover the latest updates in the pharma industry, including new regulations, company separations, and healthcare reforms.

Use of Antifungal Therapeutic Drug Monitoring Needs Improvement

A recent study has found that adherence to antifungal therapeutic drug monitoring is moderate-to-high in patients, although there is room for improvement, largely as a result of long turnaround times and uncertainty surrounding the monitoring process.

COVID-19 Viral Load Peaks Later Now Than Previously

Recent analysis of COVID-19 cases have demonstrated that viral load in Omicron infection peaks later now than it did previously in the pandemic, with older variants of the disease. Read more.

The New Era of Inflammatory Disease Treatment: Anti-TNF Adalimumab Biosimilars

This News Feature explores the impact of anti-TNF biosimilars on global healthcare as a cost-effective solution, enhancing access to treatment options for inflammatory conditions.

Higher Risk of Secondary Cancer in Young Survivors of Melanoma

According to a new study from the University of Missouri, Columbia, USA, paediatric and young adult survivors of cutaneous melanoma are at a higher risk of a second primary cancer. Read more.